Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis

Patient age, sex Scleritis type Associated disease Systemic treatment before SCI Side effects from systemic treatment Prednisone dose followed by relapse before SCI Duration of scleritis before SCI (months) Systemic treatment after SCI (last follow up) Follow up (months) Side effects from SCI 1, 57, F Nodular anterior both eyes Mixed connective tissue disease (inactive) Pred 15 mg MTX 12.5 mg Osteoporosis Weight gain 7.5 mg 63 None 22 None 2, 41, M Diffuse anterior both eyes None* Pred 9 mg MMF 2 g Pneumonia 9 mg 14 Pred 4 mg MMF 2 g 19 Transient IOP increase LE 3, 56, F Diffuse anterior both eyes Sjogren's syndrome (inactive) Pred 20 mg MTX 20 mg Weight gain Myopathy Recurrent UTI GERD 15 mg 36 Pred 5 mg MTX 25 mg 17 None 4, 11, M Diffuse anterior both eyes+ Posterior left eye None Pred 50 mg CsA 150 mg Weight gain Persistent headache 50 mg 11 Pred 10 mg 5 Subconjunctival haemorrhage, Transient IOP increase LE SCI, subconjunctival injection of triamcinolone acetonide; CsA, cyclosporine; MMF, mycophenolate mofetil; Pred, prednisone; UTI, urinary tract infection; GERD, gastro-oesophageal reflux disease.